EUVIMEDEUVIMED entdecken
Crossref

Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system

Katsuhiro Ohyama, Seiichiro Katagiri, Satoshi Takahashi, Hideaki Ayuhara, Hironori Takeuchi, Daigo Akahane, Akihiko Gotoh, Yusuke Hori

Int. Journal of Clinical Pharmacology and Therapeutics · 2025

DOI: 10.5414/cp204627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Katsuhiro Ohyama und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Aniline Compounds, Acrylamides, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aniline CompoundsAcrylamidesUnited States Food and Drug AdministrationAdverse Drug Reaction Reporting SystemsAnemia, AplasticProtein Kinase InhibitorsHumansMaleUnited StatesFemaleMiddle AgedAgedAdultAged, 80 and overAntineoplastic AgentsErbB ReceptorsDatabases, FactualIndolesPyrimidines

Substanzen

osimertinibAniline CompoundsAcrylamidesProtein Kinase InhibitorsAntineoplastic AgentsErbB ReceptorsIndolesPyrimidines

Zitieren

APA

Ohyama, K., Katagiri, S., Takahashi, S., Ayuhara, H., Takeuchi, H., Akahane, D., Gotoh, A., & Hori, Y. (2025). Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204627

Vancouver

Ohyama K, Katagiri S, Takahashi S, Ayuhara H, Takeuchi H, Akahane D, et al. Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204627

BibTeX
@article{Ohyama2025,
  author = {Ohyama, Katsuhiro and Katagiri, Seiichiro and Takahashi, Satoshi and Ayuhara, Hideaki and Takeuchi, Hironori and Akahane, Daigo and Gotoh, Akihiko and Hori, Yusuke},
  title = {Aplastic anemia associated with osimertinib: Analysis of the FDA adverse event reporting system},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.5414/cp204627}
}
Kostenlos starten →